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ABSTRACT 
Furosemide a diuretic exhibits low solubility in water and 
low bioavailability. The purpose of this study was to determine 
the effect SNEDDS formation to dissolution and diffusion of 
furosemide. SNEDDS was made with a mixture of 66% tween 80, 
26% propylene glycol, 8% oleic acid and furosemide 40mg/mL. 
Test for SNEDDS dissolution of the capsules was developed using 
USP dissolution apparatus I and compared to market products, 
furosemide suspenssion and furosemide powder. The medium 
consists of 900mL of Artificial Gastric Fluid (AGF) , phosphate 
buffer pH 5.8 at 37±0.5°C and stirred with a speed of 100rpm. 
Diffusion test of SNEDDS furosemide was conducted by using 
reversed rat intestinal bowel and compared to furosemide 
suspension and furosemide solution. The SNEDDS formulation  
could enhance the dissolution and diffusion of furosemide 
compared to the non-SNEDDS formulation. 
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INTRODUCTION 
Furosemide is a loop diuretic which is 
used in the treatment of edema, congestive 
heart failure and hypertension (Berkó et al., 
2002). Furosemide has poor and variable 
bioavailability due to poor solubility in gastric 
fluid (5-20µg/mL) (Lindenberg et al., 2004). 
Furosemide is a drug belonging to Biopharma-
ceutical Class System (BCS)  class IV (Custodio 
et al., 2008), with the low dissolution rate. This 
low dissolution rate represents the first factor 
responsible for poor bioavailability. A techno-
logical approaches are able to improve this 
property, can represent an important starting 
point for enhancing drug pharmaceutical use. 
Furosemide dosage forms development 
is being undertaken to increase solubility which 
eventually is expected to improve bio-
availability. One such development is to create 
SNEDDS. SNEDDS are isotropic mixtures of 
oil, surfactant, cosurfactant and drugs that form 
an oil nanoemulsion in water when added to 
the water phase under slowly stirring (Nazzal et 
al., 2002). These systems spontaneously form 
an nanoemulsion when exposed to Gastro 
Intestinal Tract (GIT) liquids to form oil 
droplet in water with the size in the range of 
20-200nm (Porter et al., 2008). SNEDDS      
able to improve the bioavailability of poorly 
soluble drugs by improving dissolution and 
permeability through biological membranes due 
to the present of lipid and surfactant 
(O’Driscoll, 2002). Small globule size of 
SNEEDS also provides a large surface area 
interface for drug release and absorption (Wang 
et al., 2009). Other advantags are of high 
stability, entrapment efficiency of 100%, a 
potential decrease in the dose and dose 
frequency (due to increase bioavailability), the 
potential to provide protection for the drug 
against degradation in the environment of  the 
GIT and ease of manufacturing and scale-up 
(Kale and Patravale, 2008; Shaji and Jadhav, 
2010). SNEDDS is preferred because small 
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total volume are allowed being filled into hard 
or soft gelatin capsules. SNEDDS also contain 
surfactants which are in lower amount than 
self-micro emulsifying drug delivery system 
(SMEDDS), thereby reducing the risk of 
surfactants to cause stomach irritation and 
other toxicity (Gupta et al., 2011). 
In previous studies had been obtained 
the optimum formula SNEDDS furosemide 
(Wahyuningsih et al., 2016) but has yet been 
determined the impact of the dissolution and 
diffusion of furosemide. The purpose of this 
study was to determine the effect of SNEDDS 
against dissolution and diffusion of furosemide. 
 
MATERIAL AND METHODS 
Preparation of SNEDDS 
SNEDDS was made with a mixture of 
66% tween 80, 26% propilene glycol, 8% oleic 
acid and furosemide 40mg/mL. Preparation of 
SNEDDS furosemide formula was carried out 
by mixing tween 80 and Propylene Glycol (PG) 
in vortex mixer for 1min, then added oleic acid 
and vortex again for 2.5min. 
 
Physical characteristics   
The SNEDDS of furosemide was 
characterized for transmittance,  emusification 
time and particle size. The % transmittance  of 
SNEDDS furosemide  was measured at  630nm 
using UV-Vis spectrophotometer against 
distilled water as the blank. Emusification time 
for SNEDDS furosemide was performed using 
USP dissolution apparatus II by agitation at 
100rpm. One hundred  µL of  SNEDDS 
furosemide  was added of water (500mL) at 
temperature 37ºC. The mean droplet size  was 
determined by using Particle Size Analyzer 
(Horiba Scientific SZ-100). 
 
Dissolution test 
SNEDDS furosemide was filled into soft 
gelatin capsules and stored at room 
temperature for 24h (Basalious et al., 2010). 
Test for furosemide release of the capsules was 
developed using USP dissolution apparatus I 
/basket and compared to market products, 
furosemide suspenssion and furosemide 
powder.          The  medium  consists  of  900mL  of  
AGF, phosphate buffer pH 5.8 at 37±0.5°C 
and stirred with a speed of 100rpm. At regular 
intervals, 5mL samples were taken and replaced 
with an equal volume of fresh medium to 
maintain the volume. Sample was then filtered 
using a membrane filter and the drug 
concentration was determined by mean of UV 
spectrophotometer.  
 
Diffusion test in vitro 
Diffusion test was performed using 
reverse intestine taken from Wistar male rats 
that were fasted for 20-24h prior to the test. 
Mice were sacrificed using chloroform and 
dissected the stomach along the center line of 
the body and the intestinal was separated. The 
intestine was taken  15cm from the pylorus. 
The intestinal length of 20cm, was taken then 
the intestine divided into 2 equal lengths 
approximately 10cm each. Intestinal contents 
was purged with NaCl 0.9% w/v and then gut 
was reversed with a rod diameter of 2mm. The 
intestine was attached to the cannula tube of 
Crane & Wilson then was tied to the aeration 
cannula with an effective length of 7cm. The 
study protocol had been approved by the 
Ethics Committee of Gadjah Mada University 
No. 426/KEC-LPPT/II/2016. 
Each of furosemide and furosemide 
SNEDDS solution that has been prepared was 
used as a mucosal fluid and placed in a tube test 
as much as 75mL. The tube was is then placed 
into a water bath with the temperature of 37°C. 
The serosal fluid with pH 6.2 phosphate buffer 
solution was incorporated into the intestinal  
sac  mounted on a cannula, was then inserted 
into the tube which has been conditioned           
in a waterbath. The system was aerated with 
oxygen with the velocities of approximately 
100bubbles/min. During the experiments       
must be confirmed that the entire portion of 
the intestine has been submerged in mucosal 
fluids. 
One mL aliquot was taken at 20, 40, 60 
and 80min. Each of the sample was placed into 
a test tube and then was added 2mL of zinc 
sulfate 5% w/v and 2mL of 0.3N barium 
hydroxide and was centrifuged for 25min. The 
supernatant was separated and the furosemide 
contains was measured by spectrophotometry 
method.  
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RESULT AND DISSCUSION 
Some physical properties of the 
furosemide SNEDDS obtained (Table I). 
 
Table I. Physical properties of the furosemide 
SNEDDS 
 
Parameters Average SE 
Transmittan (%) 95.773 0.0315 
Emusification time (s) 28.5 1.5 
Particle size (nm) 88.9 4.9 
 
The transparancy of the SNEDDS was 
expressed in percent transmittance. This is one 
of the characteristics of SNEDDS to be 
determined because of the effect on particle 
size. Observations clarity visually represent 
qualitative parameters spontaneity of dispersion 
(Xia et al., 2010), while the transmittance is 
close to 100% indicates that SNEDDS produce 
a clear and transparent dispersion with a 
droplet size estimated at the nanometer (Bali et 
al., 2010). When the SNEDDS formula was 
mix with water produced clear water-emulsion 
with the transmittance of more than 95%, 
indicating that the size of the droplets 
produced has met the criteria of nanoemulsion. 
Emulsification time test was performed 
to determine how fast formula SNEDDS form 
an emulsion (Zhao, 2015). The test results 
showed emulsification time less than 1min. The 
SNEDDS formula capable of forming the 
emulsion after direct contact with gastric fluid, 
to produce an emulsion system is quite clear 
(Makadia et al., 2013). 
Determining the size of the droplet is 
made to ensure that the nanometer-sized 
emulsion formed. Droplet categorized 
nanoemulsion if the file size is below 100nm  
(Doh et al., 2013). The results obtained showed 
that the droplet size was of 88.9nm. 
The release of furosemide from 
SNEDDS, suspension and other formulation 
(Figure 1). The SNEDDS showed different 
dissolution profile when compared with 
powders, suspensions or tablets on the market, 
especially at pH 1.2. In vitro release test was 
carried out in Artificial Gatro Fluid (AGF) 
solution pH 1.2 and pH 5.8 phosphate buffer 
(Figure 1). Drug release at pH 5.8 and at pH 1.2 
as shown in the dissolution efficiency (DE) 
(Table II). At pH 5.8, the drug is released 
quickly enough and complete in 2h. The release 
of furosemide lower at pH 1.2, it is because 
furosemide has pKa ~3.9. At pH 1.2, furosemide, 
particularly in the form of molecule whereas at 
pH 5.8 while keeping in ionized form furosemide 
is more soluble in water. 
 
Table II. Dissolution efficiency value 
 
Formulation 
DE Value 
AGF 
Buffer 
phosphat 5.8 
Furosemide 
powder 
5.37±0.047 28.04±0.009 
Furosemide 
SNEDDS 
36.46±0.030* 40.70±0.127* 
Furosemide 
Suspension 
4.55±0.010 46.44±0.340 
Marketed dosage 
form 
9.91±0.118 43.80±0.272 
 
Specification: *significant difference in all 
formulations (p<0.05) 
 
At pH 1.2 media, Dissolution Efficiency 
(DE) furosemide produced most of SNEDDS 
furosemide, at the pH 5.8 furosemide was not 
significantly different between the SNEDDS 
and the suspension. The DE SNEDDS 
furosemide was largest because in part  is 
affected by SNEDDS components, namely 
oleic acid, tween 80 and PG. Oleic acid was 
chosen as the oil phase in the formulation 
SNEDDS for self-emulsifying capabilities of its 
high-capacity and large drug dissolution 
(Miryala and Kurakula, 2013).  
PG can increase solubility of a 
hydrophilic surfactant such as tween 80 and the 
solubility of the drug in the oil base (Amrutkar 
et al., 2014). The results are consistent with the 
results of research conducted by Swaroopa et 
al., (2014), oleic acid formulation, water, tween 
80 and PG can increase the release of the drug 
than the formula contains oleic acid, water, 
Cremophor RH 40 and ethanol. 
From (Figure 2) that the number of 
furosemide that diffuses from SNEDDS 
furosemide greater than furosemide suspension 
and furosemide solution . The same thing can 
also (Table III) parameters of diffusion 
permeability and flux SNEDDS furosemide 
have the greatest value. Increased furosemide 
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diffusion due to the influence of each of the 
excipients used in SNEDDS which are oleic 
acid, tween 80 and PG. 
Oleic acid can act as an enhancer with 
localizes hydrophobic drug to the multilamellar 
lipid membrane (Yu et al., 2003). Oleic acid, the 
class of fatty acids, is included enhancers to 
increase the rate of diffusion by  increasing 
membrane fluidity (Hadgraft and Walters, 
1993). 
The absorption of furosemide was 
inhibited significantly by P-gp, whereas Tween 
80 showed to inhibit P-gp pump. As a result, It 
will inhibit  furosemide efflux, which the 
concentration of furosemide inside cells  is 
remain high (Al-Mohizea, 2010). Tween 80 has 
also the ability to inhibit P-gp of intestines and 
has been widely used to increase the 
permeability of various drugs in in vitro study 
(Prabhakar et al., 2013). Surfactants can increase 
     
(A)       (B) 
 
Figure 1. The profile of furosemide release in(A) AGF(pH1.2) and in (B) phosphate buffer (pH 5.8) 
at 37ºC ± 0.5 of furosemide powder, furosemide SNEDDS  and furosemide suspension. Data 
represent the average of five independent determinations ± SE and furosemide suspension. Data 
represent the average of five independent determinations ± SE. 
 
      
(A)       (B) 
 
Figure 2. In vitro drug diffusion of crude drug, furosemide SNEDDS  and furosemide suspension in 
(A) jejunum (B) ileum. Data represent the average of three independent determinations ± SE 
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fluidity of the intestinal membrane and open 
the tight junctions which resulted in an increase 
of membrane permeability (Mohsin et al., 2012; 
Porter et al., 2008; Rajesh et al., 2010).  On the 
other hand, tween 80 can also act as an 
enhancer to improve membrane permeation 
(Acharya et al., 2013). 
PG is one of the compounds to facilitate 
drug transportation to the polar lipids of 
membrane (Trommer and Neubert, 2006). It 
will increase the penetration of drugs across the 
membrane. PG is as cosolvent to produce a 
saturated solution to maximize the drug 
thermodynamic activity. PG can be used as a 
penetration enhancer at a concentration of 1% 
to 10% (Williams and Barry, 2004). 
The finding of this study consistent with 
that of Acharya et al., (2013) which proved that 
the combination among oleic acid, tween 80 
and PG can increase the diffusion of 
carbamazepine.  
 
CONCLUSION 
SNEDDS formulation can enhance the 
dissolution and diffusion of furosemide. 
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